Special Issue on "Advances in Cholesterol and Lipid Metabolism"

Overview

Journal Metabolites

Publisher MDPI

Date 2022 Aug 25

PMID 36005636

Authors

Allison B Reiss

Joshua De Leon

Affiliations

Soon will be listed here.

Abstract

Cholesterol and lipid metabolism is a broad topic that encompasses multiple aspects of cellular function in every organ [...].

References

Yang Q, Zhang Z, Gregg E, Flanders W, Merritt R, Hu F . Added sugar intake and cardiovascular diseases mortality among US adults. JAMA Intern Med. 2014; 174(4):516-24. PMC: 10910551. DOI: 10.1001/jamainternmed.2013.13563. View

Cui M, Trimigno A, Castro-Mejia J, Reitelseder S, Bulow J, Bechshoft R . Human Fecal Metabolome Reflects Differences in Body Mass Index, Physical Fitness, and Blood Lipoproteins in Healthy Older Adults. Metabolites. 2021; 11(11). PMC: 8620003. DOI: 10.3390/metabo11110717. View

Chen Z, Shrestha R, Yang X, Wu X, Jia J, Chiba H . Oxidative Stress and Lipid Dysregulation in Lipid Droplets: A Connection to Chronic Kidney Disease Revealed in Human Kidney Cells. Antioxidants (Basel). 2022; 11(7). PMC: 9312214. DOI: 10.3390/antiox11071387. View

Stellaard F . From Dietary Cholesterol to Blood Cholesterol, Physiological Lipid Fluxes, and Cholesterol Homeostasis. Nutrients. 2022; 14(8). PMC: 9025004. DOI: 10.3390/nu14081643. View

Abdul-Rahman T, Bukhari S, Herrera E, Awuah W, Lawrence J, de Andrade H . Lipid Lowering Therapy: An Era Beyond Statins. Curr Probl Cardiol. 2022; 47(12):101342. DOI: 10.1016/j.cpcardiol.2022.101342. View

Nordestgaard B, Langlois M, Langsted A, Chapman M, Aakre K, Baum H . Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM. Atherosclerosis. 2020; 294:46-61. DOI: 10.1016/j.atherosclerosis.2019.12.005. View

Jankowski J, Floege J, Fliser D, Bohm M, Marx N . Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options. Circulation. 2021; 143(11):1157-1172. PMC: 7969169. DOI: 10.1161/CIRCULATIONAHA.120.050686. View

Vecka M, Dusejovska M, Stankova B, Rychlik I, Zak A . A Matched Case-Control Study of Noncholesterol Sterols and Fatty Acids in Chronic Hemodialysis Patients. Metabolites. 2021; 11(11). PMC: 8618803. DOI: 10.3390/metabo11110774. View

Huang K, Jo H, Echesabal-Chen J, Stamatikos A . Combined LXR and RXR Agonist Therapy Increases ABCA1 Protein Expression and Enhances ApoAI-Mediated Cholesterol Efflux in Cultured Endothelial Cells. Metabolites. 2021; 11(9). PMC: 8466889. DOI: 10.3390/metabo11090640. View

10.

Zhang C, Ni J, Chen Z . Apolipoprotein B Displays Superior Predictive Value Than Other Lipids for Long-Term Prognosis in Coronary Atherosclerosis Patients and Particular Subpopulations: A Retrospective Study. Clin Ther. 2022; 44(8):1071-1092. DOI: 10.1016/j.clinthera.2022.06.010. View

11.

Zhou R, Stouffer G, Frishman W . Cholesterol Paradigm and Beyond in Atherosclerotic Cardiovascular Disease: Cholesterol, Sterol Regulatory Element-Binding Protein, Inflammation, and Vascular Cell Mobilization in Vasculopathy. Cardiol Rev. 2021; 30(5):267-273. PMC: 9351696. DOI: 10.1097/CRD.0000000000000406. View

12.

Pan X . The Roles of Fatty Acids and Apolipoproteins in the Kidneys. Metabolites. 2022; 12(5). PMC: 9145954. DOI: 10.3390/metabo12050462. View

13.

Ho W, Hartmann H, Ling S . Central nervous system cholesterol metabolism in health and disease. IUBMB Life. 2022; 74(8):826-841. DOI: 10.1002/iub.2662. View

14.

Luo J, Yang H, Song B . Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2019; 21(4):225-245. DOI: 10.1038/s41580-019-0190-7. View

15.

Boren J, Chapman M, Krauss R, Packard C, Bentzon J, Binder C . Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2020; 41(24):2313-2330. PMC: 7308544. DOI: 10.1093/eurheartj/ehz962. View

16.

Chan L, Coyle D, Wu J, Chun Yu Louie J . Total and Free Sugar Levels and Main Types of Sugars Used in 18,784 Local and Imported Pre-Packaged Foods and Beverages Sold in Hong Kong. Nutrients. 2021; 13(10). PMC: 8540970. DOI: 10.3390/nu13103404. View

17.

Gunda V, Genaro-Mattos T, Kaushal J, Chirravuri-Venkata R, Natarajan G, Mallya K . Ubiquitous Aberration in Cholesterol Metabolism across Pancreatic Ductal Adenocarcinoma. Metabolites. 2022; 12(1). PMC: 8779872. DOI: 10.3390/metabo12010047. View

18.

Haslam D, Chasman D, Peloso G, Herman M, Dupuis J, Lichtenstein A . Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults. J Nutr. 2023; 152(11):2534-2545. PMC: 9644170. DOI: 10.1093/jn/nxac166. View

19.

Deleu S, Machiels K, Raes J, Verbeke K, Vermeire S . Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?. EBioMedicine. 2021; 66:103293. PMC: 8047503. DOI: 10.1016/j.ebiom.2021.103293. View

20.

Ruscica M, Sirtori C, Carugo S, Banach M, Corsini A . Bempedoic Acid: for Whom and When. Curr Atheroscler Rep. 2022; 24(10):791-801. PMC: 9474414. DOI: 10.1007/s11883-022-01054-2. View